{
    "symbol": "CSTL",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-09 21:54:04",
    "content": " So we felt, wow, we could walk in now, we'll have to integrate, obviously, the current employee base and hire new, but the opportunity to really kind of move this through a growth system in 2023, '24, '25, '26 and beyond looked like it had awful a lot of risk taken out due to Medicare coverage due to the strong clinical publication track record, and we believe there are other disease states within the gastroenterologists marketplace that we will be looking to build up so that by the time we get to what, call it, 2025 and you turn around and say, just like dermatology was in 2022, we have 2 or 3 or 4 tests now targeted the same customer offering good value that should let us leverage our investment."
}